Antibody response after a single dose of BBV152 vaccine negatively correlates with pre-existing antibodies and induces a significant but low levels of neutralizing antibodies to Omicron variant
Suman Das, Janmejay Singh, Heena Shaman, Balwant Singh, Anbalagan Anantharaj, Patil Sharanabasava, Rajesh Pandey, Rakesh Lodha, Anil Kumar Pandey, View ORCID ProfileGuruprasad R. Medigeshi
doi: https://doi.org/10.1101/2022.02.07.22270612
Suman Das
1Employees State Insurance Corporation Medical College and Hospital, Faridabad, Haryana, INDIA
Janmejay Singh
2Translational Health Science and Technology Institute, Faridabad, Haryana. INDIA
Heena Shaman
2Translational Health Science and Technology Institute, Faridabad, Haryana. INDIA
Balwant Singh
2Translational Health Science and Technology Institute, Faridabad, Haryana. INDIA
Anbalagan Anantharaj
2Translational Health Science and Technology Institute, Faridabad, Haryana. INDIA
Patil Sharanabasava
2Translational Health Science and Technology Institute, Faridabad, Haryana. INDIA
Rajesh Pandey
3INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology, Delhi, INDIA
Rakesh Lodha
4All India Institute of Medical Sciences, New Delhi, INDIA
Anil Kumar Pandey
1Employees State Insurance Corporation Medical College and Hospital, Faridabad, Haryana, INDIA
Guruprasad R. Medigeshi
2Translational Health Science and Technology Institute, Faridabad, Haryana. INDIA
Log in using your username and password
Log in through your institution
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
Posted February 08, 2022.
Antibody response after a single dose of BBV152 vaccine negatively correlates with pre-existing antibodies and induces a significant but low levels of neutralizing antibodies to Omicron variant
Suman Das, Janmejay Singh, Heena Shaman, Balwant Singh, Anbalagan Anantharaj, Patil Sharanabasava, Rajesh Pandey, Rakesh Lodha, Anil Kumar Pandey, Guruprasad R. Medigeshi
medRxiv 2022.02.07.22270612; doi: https://doi.org/10.1101/2022.02.07.22270612
Antibody response after a single dose of BBV152 vaccine negatively correlates with pre-existing antibodies and induces a significant but low levels of neutralizing antibodies to Omicron variant
Suman Das, Janmejay Singh, Heena Shaman, Balwant Singh, Anbalagan Anantharaj, Patil Sharanabasava, Rajesh Pandey, Rakesh Lodha, Anil Kumar Pandey, Guruprasad R. Medigeshi
medRxiv 2022.02.07.22270612; doi: https://doi.org/10.1101/2022.02.07.22270612
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12719)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (923)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6923)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (384)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)